Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02315456 · ClinicalTrials.gov registry record · NA

Evaluation of Centration of Intraocular Lens With Two Settings for Capsulorhexis With Femtosecond Laser

A NA study of Capsulorhexis, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT02315456: Completed NA study of Capsulorhexis, sponsored by Northwestern University.

NCT02315456 is a NA study of Capsulorhexis that has completed, run by Northwestern University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02315456, a NA study of Capsulorhexis, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The study compares anatomic outcomes of Intra Ocular Lens(IOL) placement with two methods of centration of the capsulorhexis- scanned capsule centration and pupil centration. It is hypothesized that scanned capsule centration provides more uniform(25% better) overlap of capsulorhexis margin over IOL optic compared to pupil centration.

Primary Outcome

The horizontal and vertical overlap will be calculated. Horizontal overlap= Overlap of the temporal half versus the nasal half Vertical overlap= overlap of the superior half versus the inferior half of the IOL. Symmetricity of overlap= Horizontal overlap/vertical overlap

Conditions Studied

Interventions

  • PROCEDURE capsulorhexis

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2014-12
Est. Completion 2016-08-09
Phase NA
Northwestern University

1,209 total trials

What the finished NCT02315456 record still lists

NCT02315456 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Capsulorhexis appearing as the primary indexed condition, and to 1 intervention - of which capsulorhexis is the first listed.

NCT02315456 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT02315456 about?

NCT02315456 is a clinical study titled "Evaluation of Centration of Intraocular Lens With Two Settings for Capsulorhexis With Femtosecond Laser". The study compares anatomic outcomes of Intra Ocular Lens(IOL) placement with two methods of centration of the capsulorhexis- scanned capsule centration and pupil centration. It is hypothesized that scanned capsule centration provides more uniform(25% better) overlap of capsulorhexis margin over IOL...

What is the current status of trial NCT02315456?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2014-12. Estimated completion is 2016-08-09.

What conditions does trial NCT02315456 study?

This clinical trial studies the following conditions: Capsulorhexis.

What interventions are being tested in trial NCT02315456?

The interventions under investigation include: capsulorhexis (PROCEDURE).

Who is sponsoring clinical trial NCT02315456?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02315456 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT02315456's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02315456, the US trial registry maintained by the National Library of Medicine. NCT02315456 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.